Literature DB >> 25802317

Where is hippocampal activity in the cascade of Alzheimer's disease biomarkers?

Howard J Aizenstein1, William E Klunk2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25802317      PMCID： PMC4438386          DOI： 10.1093/brain/awv001

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  10 in total

1.  Encoding novel face-name associations: a functional MRI study.

Authors:  R A Sperling; J F Bates; A J Cocchiarella; D L Schacter; B R Rosen; M S Albert
Journal:  Hum Brain Mapp       Date:  2001-11       Impact factor: 5.038

2.  Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Clifford R Jack; Marilyn S Albert; David S Knopman; Guy M McKhann; Reisa A Sperling; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

Review 3.  Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial.

Authors:  S M Mills; J Mallmann; A M Santacruz; A Fuqua; M Carril; P S Aisen; M C Althage; S Belyew; T L Benzinger; W S Brooks; V D Buckles; N J Cairns; D Clifford; A Danek; A M Fagan; M Farlow; N Fox; B Ghetti; A M Goate; D Heinrichs; R Hornbeck; C Jack; M Jucker; W E Klunk; D S Marcus; R N Martins; C M Masters; R Mayeux; E McDade; J C Morris; A Oliver; J M Ringman; M N Rossor; S Salloway; P R Schofield; J Snider; P Snyder; R A Sperling; C Stewart; R G Thomas; C Xiong; R J Bateman
Journal:  Rev Neurol (Paris)       Date:  2013-09-06       Impact factor: 2.607

4.  Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.

Authors:  Rachelle S Doody; Ronald G Thomas; Martin Farlow; Takeshi Iwatsubo; Bruno Vellas; Steven Joffe; Karl Kieburtz; Rema Raman; Xiaoying Sun; Paul S Aisen; Eric Siemers; Hong Liu-Seifert; Richard Mohs
Journal:  N Engl J Med       Date:  2014-01-23       Impact factor: 91.245

Review 5.  Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.

Authors:  Eric M Reiman; Jessica B S Langbaum; Adam S Fleisher; Richard J Caselli; Kewei Chen; Napatkamon Ayutyanont; Yakeel T Quiroz; Kenneth S Kosik; Francisco Lopera; Pierre N Tariot
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

6.  Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression.

Authors:  Willem Huijbers; Elizabeth C Mormino; Aaron P Schultz; Sarah Wigman; Andrew M Ward; Mykol Larvie; Rebecca E Amariglio; Gad A Marshall; Dorene M Rentz; Keith A Johnson; Reisa A Sperling
Journal:  Brain       Date:  2015-02-11       Impact factor: 13.501

7.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

8.  Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve.

Authors:  Ann D Cohen; Julie C Price; Lisa A Weissfeld; Jeffrey James; Bedda L Rosario; Wenzhu Bi; Robert D Nebes; Judith A Saxton; Beth E Snitz; Howard A Aizenstein; David A Wolk; Steven T Dekosky; Chester A Mathis; William E Klunk
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

9.  The A4 study: stopping AD before symptoms begin?

Authors:  Reisa A Sperling; Dorene M Rentz; Keith A Johnson; Jason Karlawish; Michael Donohue; David P Salmon; Paul Aisen
Journal:  Sci Transl Med       Date:  2014-03-19       Impact factor: 17.956

10.  Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Authors:  Stephen Salloway; Reisa Sperling; Nick C Fox; Kaj Blennow; William Klunk; Murray Raskind; Marwan Sabbagh; Lawrence S Honig; Anton P Porsteinsson; Steven Ferris; Marcel Reichert; Nzeera Ketter; Bijan Nejadnik; Volkmar Guenzler; Maja Miloslavsky; Daniel Wang; Yuan Lu; Julia Lull; Iulia Cristina Tudor; Enchi Liu; Michael Grundman; Eric Yuen; Ronald Black; H Robert Brashear
Journal:  N Engl J Med       Date:  2014-01-23       Impact factor: 91.245
  10 in total
  6 in total

1.  Association of Hippocampal Substructure Resting-State Functional Connectivity with Memory Performance in Older Adults.

Authors:  Stephen F Smagula; Helmet T Karim; Anusha Rangarajan; Fernando Pasquini Santos; Sossena C Wood; Tales Santini; John M Jakicic; Charles F Reynolds; Judy L Cameron; Abbe N Vallejo; Meryl A Butters; Caterina Rosano; Tamer S Ibrahim; Kirk I Erickson; Howard J Aizenstein
Journal:  Am J Geriatr Psychiatry       Date:  2018-03-13       Impact factor: 4.105

2.  Relationships Between Executive Control Circuit Activity, Amyloid Burden, and Education in Cognitively Healthy Older Adults.

Authors:  Helmet T Karim; Dana L Tudorascu; Ann Cohen; Julie C Price; Brian Lopresti; Chester Mathis; William Klunk; Beth E Snitz; Howard J Aizenstein
Journal:  Am J Geriatr Psychiatry       Date:  2019-07-19       Impact factor: 4.105

3.  Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics During Alzheimer's Disease Progression.

Authors:  Caleigh A Findley; Andrzej Bartke; Kevin N Hascup; Erin R Hascup
Journal:  ASN Neuro       Date:  2019 Jan-Dec       Impact factor: 4.146

4.  Targeting hippocampal hyperactivity with real-time fMRI neurofeedback: protocol of a single-blind randomized controlled trial in mild cognitive impairment.

Authors:  Katharina Klink; Urs Jaun; Andrea Federspiel; Marina Wunderlin; Charlotte E Teunissen; Claus Kiefer; Roland Wiest; Frank Scharnowski; Ronald Sladky; Amelie Haugg; Lydia Hellrung; Jessica Peter
Journal:  BMC Psychiatry       Date:  2021-02-09       Impact factor: 3.630

5.  Episodic Memory, Hippocampal Volume, and Function for Classification of Mild Cognitive Impairment Patients Regarding Amyloid Pathology.

Authors:  Eliane Correa Miotto; Sonia Maria Dozzi Brucki; Carlos T Cerqueira; Paulo R Bazán; Geise Aline de Almeida Silva; Maria da Graça M Martin; Paula Squarzoni da Silveira; Daniele de Paula Faria; Artur Martins Coutinho; Carlos Alberto Buchpiguel; Geraldo Busatto Filho; Ricardo Nitrini
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

6.  Imminent cognitive decline in normal elderly individuals is associated with hippocampal hyperconnectivity in the variant neural correlates of episodic memory.

Authors:  Hao Shu; Gang Chen; B Douglas Ward; Guangyu Chen; Zan Wang; Duan Liu; Fan Su; Lihua Gu; Zhan Xu; Shi-Jiang Li; Zhijun Zhang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-08-07       Impact factor: 5.760
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.